|AMEUF -- USA Stock|| |
USD 0.20 0.022 12.09%
Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Admedus Limited is 'Strong Sell'
. Macroaxis provides Admedus Limited buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Admedus positions. The advice algorithm takes into account all of Admedus Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Admedus buy-and-hold prospective. Check also Admedus Analyst Recommendation
to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.
Admedus Current Recommendation
For the selected time horizon Admedus Limited has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
We provide buy or sell advice to complement the prevailing expert consensus
on Admedus Limited. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Admedus is not overpriced, please confirm all Admedus Limited fundamentals including its Debt to Equity
, Total Asset
and the relationship
between Net Income
and Earnings Per Share
. As Admedus Limited
appears to be a penny stock we also recommend to validate its Price to Book
Admedus Volatility Alert
Admedus Limited exhibits very low volatility with skewness of 0.0 and kurtosis of 0.0. However, we advise investors to further study Admedus Limited technical indicators to make sure all market info is available and is reliable. Admedus Limited is a potential penny stock. Although Admedus may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in Admedus Limited. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
Admedus Fundamental Vs Peers
|Admedus Limited generates negative expected return over the last 30 days|
|Admedus Limited has some characteristics of a very speculative penny stock|
|Admedus Limited has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations|
|The company reported revenue of 16.19 M. Net Loss for the year was (11.01 M) with profit before overhead, payroll, taxes, and interest of 10.29 M. |
|ADMEDUS has accumulated about 6.25 M in cash with (7.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. |
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. Technology theme has 30 constituents.
Check also Admedus Analyst Recommendation
to compare Macroaxis Buy or Sell Recommendation with current analyst consensus. Please also try Financial Widgets
module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.